JYQ-173 is a selective inhibitor of the human Parkinsons disease protein 7 (PARK7) with an IC50 of 19 nM. It possesses excellent cell permeability and acts as a ligand for target protein PARK7, making it suitable for synthesizing PROTACDegraderJYQ-194.
Formula:
C21H19FN8O2S
Target:
Ligands for Target Protein for PROTAC
* VAT and and shipping costs not included. Errors and price changes excepted
